Passion and Aptitude

Rebeca Stiepel received the 2022 Kathryne A. Brewington Graduate Research Award

Rebeca Stiepel

Rebeca Stiepel received the 2022 Kathryne A. Brewington Graduate Research Award

PhD student Rebeca Stiepel is the 2022 recipient of the UNC Eshelman School of Pharmacy’s Kathryne A. Brewington Graduate Research Award.

The school presents the award annually to the most outstanding doctoral student in pharmaceutical sciences in honor of Kathryne Brewington, who passed away while pursuing her doctoral degree at the school.

The award is supported by the Kathryne Brewington Memorial Fund established by Kathryne’s father, Thomas Brewington, and held at the Pharmacy Foundation of North Carolina. The winner receives a plaque and a $1,500 grant that can be used to fund research, develop new research skills or present dissertation work.

Stiepel studies in the school’s division of pharmacoengineering and molecular pharmaceutics under advisor Kristy Ainslie, Ph.D. Her graduate research focuses on developing an antigen-specific treatment for autoimmune disorders. She is currently working on a “tolerogenic vaccine” for multiple sclerosis.

“From when Rebeca first started in my lab as a SOLAR undergraduate student, it was clear that she had an outstanding passion and aptitude for research, particularly in pharmaceutical sciences,” Ainslie said. “As she began to pursue a Ph.D. in my lab, that effort has only blossomed and she has been able to accomplish so much, including several first author publications and awards for poster presentations. It’s an honor to have one of my students receive the Kathryne A. Brewington Graduate Research Award.”

Read the complete Carolina Story…Opens in new window

UNC Eshelman School of Pharmacy Funding Priorities

Readers Also Viewed...

Shawn Hingtgen and Jillian Perry

Treating the Untreatable

New research funded by a NIH grant seeks to combat one of the most treatment-resistant cancers

Dr. David Drewry at the Genetic Medicine Building on the campus of UNC-Chapel Hill .

Collaborating for a Cure

Drug treatments for a rare form of cancer have eluded researchers for years. Work at the UNC Eshelman School of Pharmacy has scientists and survivors optimistic that big breakthroughs are within reach.

Two scientists look at test tubes

Fighting Future Pandemics

SAS Joins READDI in the Fight to Prevent Future Pandemics

Qisheng Zhang portrait

Identifying New Therapeutics

Eshelman professor secures secures $2.2 million to develop leukemia, lymphoma treatment.

Pharmacists practicing to administer a vaccine.

Future Pharmacists at the Ready

“We are preparing ourselves… to be key administers of this vaccine.”


Discovering Disease Treatments

Strengthening neuroscience research